IVITX
Price
$19.45
Change
+$0.26 (+1.35%)
Updated
Aug 12 closing price
Net Assets
152.65M
VIVAX
Price
$70.03
Change
+$0.74 (+1.07%)
Updated
Aug 12 closing price
Net Assets
195.81B
Interact to see
Advertisement

IVITX vs VIVAX

Header iconIVITX vs VIVAX Comparison
Open Charts IVITX vs VIVAXBanner chart's image
VY® Invesco Growth and Income S2
Price$19.45
Change+$0.26 (+1.35%)
VolumeN/A
Net Assets152.65M
Vanguard Value Index I
Price$70.03
Change+$0.74 (+1.07%)
VolumeN/A
Net Assets195.81B
IVITX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IVITX vs. VIVAX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVITX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 196B vs. IVITX (153M). VIVAX pays higher dividends than IVITX: VIVAX (2.06) vs IVITX (0.49). IVITX was incepted earlier than VIVAX: IVITX (23 years) vs VIVAX (33 years). IVITX (1.04) is less costly to investors than VIVAX (0.17). IVITX is a more actively managed with annual turnover of: 30.00 vs. VIVAX (9.00). IVITX has a lower initial minimum investment than VIVAX: IVITX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 9.23 vs. IVITX (-6.34). VIVAX return over 5 years is better than : 66.39 vs. IVITX (15.91).
IVITXVIVAXIVITX / VIVAX
Total Expense Ratio1.040.17612%
Annual Report Gross Expense Ratio1.040.17612%
Fund Existence23 years33 years-
Gain YTD-13.1354.937-266%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets153M196B0%
Annual Yield % from dividends0.492.0624%
Returns for 1 year-6.349.23-69%
Returns for 3 years-8.8724.78-36%
Returns for 5 years15.9166.3924%
Returns for 10 years-17.36111.79-16%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMAB21.870.79
+3.75%
Genmab A/S ADS
PVLA43.211.50
+3.60%
Palvella Therapeutics Inc
KTTA0.700.02
+3.17%
Pasithea Therapeutics Corp
TRUP50.661.17
+2.36%
Trupanion
QIPT1.98-0.14
-6.60%
Quipt Home Medical Corp